| Katie Holzheimer, | |
|
800 S Main Ave, Rugby, ND 58368-2118 | |
| (701) 776-5235 | |
| Not Available |
| Full Name | Katie Holzheimer |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 4 Years |
| Location | 800 S Main Ave, Rugby, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366053571 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 2363 (North Dakota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Good Samaritan Hospital Association | 6002716701 | 15 |
News Archive
Efforts to treat pediatric papillary thyroid cancer are greatly improved by detecting the disease as early as possible, making the patient's age the most important factor in determining a prognosis, according to new research published in the February 2008 issue of the journal Otolaryngology Head and Neck Surgery.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
The United States Department of Health and Human Services has announced the delivery of thousands of interactive women's health books built with the LeapPad learning system technology to Afghanistan and an additional $6 million in aid to improve the health of the Afghan people.
› Verified 1 days ago
| Provider Name | Good Samaritan Hospital Association |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1588751325 PECOS PAC ID: 6002716701 Enrollment ID: O20040225000266 |
News Archive
Efforts to treat pediatric papillary thyroid cancer are greatly improved by detecting the disease as early as possible, making the patient's age the most important factor in determining a prognosis, according to new research published in the February 2008 issue of the journal Otolaryngology Head and Neck Surgery.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
The United States Department of Health and Human Services has announced the delivery of thousands of interactive women's health books built with the LeapPad learning system technology to Afghanistan and an additional $6 million in aid to improve the health of the Afghan people.
› Verified 1 days ago
| Provider Name | Good Samaritan Hospital Association |
|---|---|
| Provider Type | Part A Provider - Critical Access Hospital |
| Provider Identifiers | NPI Number: 1437258969 PECOS PAC ID: 6002716701 Enrollment ID: O20070420000398 |
News Archive
Efforts to treat pediatric papillary thyroid cancer are greatly improved by detecting the disease as early as possible, making the patient's age the most important factor in determining a prognosis, according to new research published in the February 2008 issue of the journal Otolaryngology Head and Neck Surgery.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
The United States Department of Health and Human Services has announced the delivery of thousands of interactive women's health books built with the LeapPad learning system technology to Afghanistan and an additional $6 million in aid to improve the health of the Afghan people.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katie Holzheimer, Po Box 556, Casselton, ND 58012-0556 Ph: () - | Katie Holzheimer, 800 S Main Ave, Rugby, ND 58368-2118 Ph: (701) 776-5235 |
News Archive
Efforts to treat pediatric papillary thyroid cancer are greatly improved by detecting the disease as early as possible, making the patient's age the most important factor in determining a prognosis, according to new research published in the February 2008 issue of the journal Otolaryngology Head and Neck Surgery.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the fourth quarter and year ended December 31, 2010.
Apricus Biosciences, backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT drug delivery technology and internal pipeline through out-licensing arrangements and partnerships, today announced results from a pre-clinical pharmacokinetic study showing the ability of NexACT to enable rectal delivery of biologics, such as human antibodies.
The United States Department of Health and Human Services has announced the delivery of thousands of interactive women's health books built with the LeapPad learning system technology to Afghanistan and an additional $6 million in aid to improve the health of the Afghan people.
› Verified 1 days ago
Rebecca Anne Kraft, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 800 S Main Ave, Rugby, ND 58368 Phone: 701-776-5261 Fax: 701-776-5448 | |
Kayla K Johnson, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 S Main Ave, Rugby, ND 58368 Phone: 701-776-5261 Fax: 701-776-5448 | |
Winter Fawn Monette, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 800 S Main Ave, Rugby, ND 58368 Phone: 701-776-5455 | |
Shea Heidlebaugh, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 S Main Ave, Rugby, ND 58368 Phone: 701-776-5455 | |
Jordan Backstrom, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 215 Highway 2 Sw Stuite 103, Rugby, ND 58368 Phone: 701-351-0775 | |
Kayla Hamilton, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 800 S Main Ave, Rugby, ND 58368 Phone: 701-776-5455 |